OptimizeRx Corp
OPRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$163.63M
Close$
$6.39
27.3% downside
Current Fair Value
27.3% downsideOvervalued by 27.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $163.63 Million |
|---|---|
| Enterprise Value | $159.72 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.28 |
| Beta | 1.05 |
| Outstanding Shares | 18,785,596 |
Return
| Return on Equity | 3.51% |
|---|---|
| Return on Assets | 2.80% |
| Return on Invested Capital | 0.72% |
Valuation & Multiples
| P/E Ratio | 35.8 |
|---|---|
| PEG | -24.54 |
| Price to Sales | 1.76 |
| Price to Book Ratio | 1.46 |
| Enterprise Value to Revenue | 1.62 |
| Enterprise Value to EBIT | 144.03 |
| Enterprise Value to Net Income | 34 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$20.20 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 46.13% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 9.26%▼ 63.74% |
|---|---|
| Total Invested | $9.95M▼ 88.41% |
| Investors Holding | 34▼ 98.00% |
ESG Score
No data
About OptimizeRx Corp
OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary ne...